MEDSABOR: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDSABOR
Largest movements
- Financial fixed assets -€279,066
no longer reported in 2025 (was €279,066)
- Receivables within one year +€156,940
up €156,940 (+1036.0%), from €15,149 to €172,089
of which Other amounts receivable: +€155,689
- Cash -€26,159
down €26,159 (-80.4%), from €32,522 to €6,363
mainly Contributions, distributions and other (-€191,000) and Receivables within one year (-€156,940)
- Reserves -€162,010
down €162,010 (-69.8%), from €232,079 to €70,069
- Tax, wage and social debts +€9,886
new in 2025: €9,886
- Financial income +€22,187
up €22,187 (+559.8%), from €3,964 to €26,151
- Taxes +€10,410
up €10,410 (+221.0%), from €4,710 to €15,119
- Gross operating margin +€10,133
up €10,133 (+84.8%), from €11,956 to €22,089
- Financial charges +€2,239
up €2,239 (+5394.8%), from €42 to €2,280
- Other operating charges -€408
down €408 (-50.5%), from €807 to €400
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €335,588 | €183,324 | -€152,264 | -45.4% |
| Fixed assets | 21/28 | €282,671 | €2,163 | -€280,508 | -99.2% |
| Tangible fixed assets | 22/27 | €3,605 | €2,163 | -€1,443 | -40.0% |
| Land and buildings | 22 | €3,605 | €2,163 | -€1,443 | -40.0% |
| Financial fixed assets | 28 | €279,066 | - | -€279,066 | |
| Current assets | 29/58 | €52,918 | €181,162 | +€128,244 | +242.3% |
| Amounts receivable within one year | 40/41 | €15,149 | €172,089 | +€156,940 | +1036.0% |
| Trade receivables | 40 | - | €1,251 | +€1,251 | |
| Other amounts receivable | 41 | €15,149 | €170,838 | +€155,689 | +1027.7% |
| Cash at bank and in hand | 54/58 | €32,522 | €6,363 | -€26,159 | -80.4% |
| Deferred charges and accrued income | 490/1 | €5,246 | €2,709 | -€2,537 | -48.4% |
| Total equity and liabilities | 10/49 | €335,588 | €183,324 | -€152,264 | -45.4% |
| Equity | 10/15 | €335,104 | €173,103 | -€162,002 | -48.3% |
| Contributions | 10/11 | €12,397 | €12,397 | = | 0.0% |
| Reserves | 13 | €232,079 | €70,069 | -€162,010 | -69.8% |
| Non-distributable reserves | 130/1 | €232,079 | €70,069 | -€162,010 | -69.8% |
| Reserves not available under the articles | 1311 | €232,079 | €70,069 | -€162,010 | -69.8% |
| Profit (loss) carried forward | 14 | €90,628 | €90,636 | +€8 | 0.0% |
| Amounts payable | 17/49 | €484 | €10,222 | +€9,738 | +2012.0% |
| Amounts payable within one year | 42/48 | €484 | €10,222 | +€9,738 | +2012.0% |
| Trade debts | 44 | €484 | €336 | -€148 | -30.6% |
| Suppliers | 440/4 | €484 | €336 | -€148 | -30.6% |
| Taxes, remuneration and social security | 45 | - | €9,886 | +€9,886 | |
| Taxes | 450/3 | - | €9,886 | +€9,886 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,358 | €1,443 | +€84 | +6.2% |
| Other operating charges | 640/8 | €807 | €400 | -€408 | -50.5% |
| Gross operating margin | 9900 | €11,956 | €22,089 | +€10,133 | +84.8% |
| Operating profit (loss) | 9901 | €9,791 | €20,247 | +€10,456 | +106.8% |
| Financial income | 75/76B | €3,964 | €26,151 | +€22,187 | +559.8% |
| Recurring financial income | 75 | €3,964 | €26,151 | +€22,187 | +559.8% |
| Financial charges | 65/66B | €42 | €2,280 | +€2,239 | +5394.8% |
| Recurring financial charges | 65 | €42 | €2,280 | +€2,239 | +5394.8% |
| Profit (loss) for the period before taxes | 9903 | €13,713 | €44,118 | +€30,405 | +221.7% |
| Income taxes | 67/77 | €4,710 | €15,119 | +€10,410 | +221.0% |
| Profit (loss) for the period | 9904 | €9,003 | €28,998 | +€19,995 | +222.1% |
| Profit (loss) for the period to be appropriated | 9905 | €9,003 | €28,998 | +€19,995 | +222.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.